Meningitis B in Reading: What Parents and Students Need to Know

A Henley College student has died. Two others are being treated. The strain is different from the Kent outbreak. Here's everything confirmed so far — and what to do if you are concerned.

Breaking — published May 15, 2026. This article will be updated as information develops.

A student at Henley College has died and two other young people are being treated following an outbreak of meningitis in Reading. One of the cases has been confirmed as meningitis B.

It is understood that the most recent case in Berkshire is not the same strain of MenB linked to the outbreaks in Kent in March. The two outbreaks are separate events — connected by the same broad bacterial group but caused by different strains of Neisseria meningitidis serogroup B.

The other two cases are linked to schools in the Reading area. Dr Paddy Woodman, director of student services at the University of Reading, noted that while no cases have been reported among university students, the institution is taking proactive steps to remind students about meningitis symptoms and the importance of checking vaccination status.

The UKHSA said that its specialists were working with local authority and NHS partners following three cases of meningococcal infection in young people in Reading. Close contacts of the cases are being offered antibiotics as a precaution. The risk to the wider public currently remains low.

TL;DR

• A Henley College student has died and two other young people are being treated at Royal Berkshire Hospital following a meningitis outbreak in Reading on 14 May 2026. One case has been confirmed as meningitis B.
• The Reading strain is not the same strain of MenB linked to the Kent outbreak in March 2026 — these are two separate, unconnected outbreaks.
• The other two cases are linked to schools in the Reading area. No cases have been reported among University of Reading students.
• Close contacts are being offered antibiotics. The UKHSA states the risk to the wider public remains low. Staff and students can attend Henley College as usual. There are currently no plans for a local emergency vaccination programme.
• The MenACWY vaccine given in schools does not protect against MenB. Students and young adults not vaccinated against MenB are not protected against this strain.
• If any meningitis symptoms develop — fever, severe headache, stiff neck, sensitivity to light, rash that does not fade under pressure — call 999 or go to A&E immediately. Do not wait.

What Has Happened

Specialists from the UKHSA South East are working with local authority and NHS partners. One case has been confirmed as meningitis B and other tests are being carried out. Students and parents at all affected schools are being offered information about signs and symptoms.

The Hart Surgery in Henley-on-Thames confirmed it had been in contact with the UKHSA regarding the death and stated that if you have not been contacted by the UKHSA, you do not currently require any treatment. Staff and students have been advised they can attend Henley College as usual. The number of confirmed cases is very low and there are currently no plans for a local emergency meningitis vaccination programme.

The strain distinction is important and should not be overlooked. It is understood the Reading case is a different strain from the one linked to the cluster of fatal cases in Kent earlier this year. This means the Reading outbreak is an independent event — not a continuation or spread of the Canterbury cluster. Two separate MenB outbreaks in UK student populations within two months does not indicate a single spreading strain. It does reflect the ongoing background risk of meningococcal disease in young adults — particularly those not vaccinated against MenB.

Dr Rachel Mearkle, consultant in health protection at UKHSA, said: "Students and staff will naturally be feeling worried about the likelihood of further cases, however meningococcal meningitis requires very close contact to spread and large outbreaks as we saw in Kent recently are thankfully rare. Meningococcal disease does not spread easily and the risk to the wider public remains low."

What Is Meningitis B — and Why It Affects Young People

Meningitis B is caused by Neisseria meningitidis group B — one of several strains of the meningococcal bacteria. It is the most common cause of bacterial meningitis in the UK.

The bacteria are often carried harmlessly in the nose and throat — around 10% of the general population carry them without ever becoming ill. In adolescents and young adults, carriage rates are higher. Transmission requires close, prolonged contact such as coughing, sneezing, or kissing, and even among carriers only a very small proportion ever develop invasive disease.

Meningococcal group B disease can lead to meningitis — inflammation of the lining of the brain and spinal cord — or to a bloodstream infection known as septicaemia. Even with treatment it can be fatal in 8 to 15% of cases, and survivors may experience long-term complications such as hearing loss, neurological damage, or limb loss.

Around 300 to 400 cases of meningococcal disease are diagnosed in England every year. The disease is most common in babies, young children, teenagers, and young adults. The concentration of cases in student populations reflects both the higher carriage rates in this age group and the close contact environments — shared accommodation, socialising, kissing — in which transmission is more likely.

Symptoms: Act Immediately

Meningitis Now chief executive Dr Tom Nutt said symptoms can appear in any order and may include a high temperature, severe headache, vomiting, stiff neck, sensitivity to light, confusion, drowsiness, cold hands and feet, severe muscle pain, and a rash that does not fade under pressure. Meningitis can become life-threatening very quickly and early diagnosis and treatment are absolutely vital.

The rash — caused by bleeding under the skin from meningococcal septicaemia — is the most well-known sign. The glass test: press a clear glass firmly against the rash. If it does not fade, call 999 immediately.

But the rash is often a late sign. Earlier symptoms — sudden high temperature, severe headache, stiff neck, sensitivity to light, and unexplained drowsiness or confusion — should prompt emergency action before a rash appears.

If you or someone you know develops these symptoms, seek medical help urgently by going to your nearest A&E or calling 999. If a friend goes to bed unwell, check on them regularly. Early treatment can be lifesaving. You can also contact your GP or call NHS 111, but do not wait — call 999 in an emergency.

The Vaccination Gap

Both the Kent and Reading outbreaks highlight the same vaccination gap in the UK schedule.

Teenagers in the UK are routinely offered a MenACWY vaccine — usually in Year 9 — but this does not protect against MenB. Even those vaccinated at school still need two doses of the MenB vaccine for protection against this strain.

The MenB vaccine — Bexsero — is given free on the NHS to babies at 8 weeks, 16 weeks, and one year. It is not currently part of the routine adolescent or young adult vaccination schedule. The JCVI does not currently recommend a routine MenB booster for adolescents and young adults.

This means the majority of teenagers and young adults in UK colleges and universities are not protected against MenB through routine vaccination. The MenB vaccine is available privately for adolescents and young adults not covered by the NHS baby schedule — a GP or pharmacy can advise on availability, timing, and cost.

Vaccination cannot provide immediate protection during an active outbreak — the vaccine requires two doses several weeks apart, and a further couple of weeks after the second dose for full protection. The way to control a current outbreak is with antibiotics. But for those not in an active outbreak area, private MenB vaccination is a meaningful preventive measure — particularly given two UK student outbreaks within two months.

What the University of Reading Is Doing

Dr Paddy Woodman, director of student services at the University of Reading, said: "While there are no reported cases among University of Reading students, I know that our students, staff and family members may be concerned. We will be contacting students to remind them of existing information about looking out for signs of meningitis and the importance of acting immediately on any worrying symptoms, as well as checking their vaccination status."

This proactive communication reflects the lessons of the Kent outbreak — where rapid public health communication and broad awareness of symptoms was central to identifying cases quickly and limiting spread.

Frequently Asked Questions

Is the Reading meningitis B outbreak the same as the Kent outbreak?

No — it is understood that the Reading case is not the same strain of MenB linked to the Kent outbreak in March 2026. These are two separate, unconnected outbreaks caused by different strains of Neisseria meningitidis serogroup B. The coincidence of two MenB outbreaks in UK student populations within two months reflects the background risk of the disease in this age group rather than a single spreading event.

How many cases are there in Reading?

Three cases of meningococcal infection have been confirmed in young people in Reading. One person — a Henley College student — has died. Two others are being treated at Royal Berkshire Hospital. The other two cases are linked to schools in the Reading area.

Should I be worried if I live in Reading?

The UKHSA states the risk to the wider public currently remains low. Meningococcal disease does not spread easily — it requires very close, prolonged contact to transmit. If you have not been contacted by the UKHSA you do not currently require treatment. Be aware of symptoms and act immediately if they develop.

What are the symptoms of meningitis B?

Symptoms include high temperature, severe headache, vomiting, stiff neck, sensitivity to light, confusion, drowsiness, cold hands and feet, severe muscle pain, and a rash that does not fade under pressure. They can appear in any order. The illness can become life-threatening within hours. Call 999 or go to A&E immediately if symptoms develop — do not wait.

Does the school meningitis vaccine protect against MenB?

No — the MenACWY vaccine offered in schools does not protect against MenB. Students need two doses of the separate MenB vaccine for protection against this strain. The MenB vaccine is given to babies on the NHS schedule but is not routinely offered to teenagers or young adults. It is available privately — ask your GP.

Can I still attend Henley College?

Yes — staff and students have been advised they can attend Henley College as usual. If you have not been contacted by the UKHSA you do not currently require any treatment.

The Bottom Line

The Henley College meningitis B outbreak is the second meningococcal cluster in a UK student population within two months — though it is a different strain from the Kent outbreak and there is no evidence of a link between the two events.

One young person has died. Two others are being treated. The UKHSA is managing the response, close contacts are being offered antibiotics, and the immediate public risk is low.

The most important practical messages are unchanged from every meningitis B outbreak: know the symptoms, act immediately if they appear, and check your MenB vaccination status. The school MenACWY vaccine does not protect against MenB. If you are a teenager or young adult who has not received two doses of the MenB vaccine, speak to your GP about private vaccination.

We will update this article as information develops. For the latest guidance visit the UKHSA website or call NHS 111.

---

Related reading: Travel Health in 2026: Vaccines, Risks and What the Hondius Outbreak Changes · Andes Virus: Why the MV Hondius Outbreak Has Changed Everything

Popular Articles